Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Arcturus Therapeutics Holdings Inc
(NQ:
ARCT
)
9.015
+0.175 (+1.98%)
Streaming Delayed Price
Updated: 11:47 AM EDT, Apr 17, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Arcturus Therapeutics Holdings Inc
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Arcturus Therapeutics to Present at the Following Investor Conferences in November
November 07, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday
↗
November 03, 2022
Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results.
Via
Benzinga
Why Arcturus Therapeutics Stock Is Skyrocketing Today
↗
November 02, 2022
Investors are applauding Arcturus' collaboration with CSL.
Via
The Motley Fool
United Therapeutics, Super Micro Computer, Novo Nordisk And Other Big Gainers From Wednesday
↗
November 03, 2022
U.S. stocks closed lower on Wednesday, with the Dow Jones dropping more than 500 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day Session
↗
November 02, 2022
Gainers Starry Group Holdings, Inc. (NYSE: STRY) gained 56% to $0.2808 after reporting Q3 results.
Via
Benzinga
Where Arcturus Therapeutics Stands With Analysts
↗
November 02, 2022
Arcturus Therapeutics (NASDAQ:ARCT) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Arcturus Shares Jump After Collaboration With CSL For mRNA-Based Vaccines
↗
November 02, 2022
Via
Benzinga
Why Is Rogers Corporation (ROG) Stock Down 44% Today?
↗
November 02, 2022
Rogers Corporation (ROG) stock is falling hard on Wednesday following confirmation that DuPont (DD) no longer plans to acquire the company.
Via
InvestorPlace
Why Is Benefitfocus (BNFT) Stock Up 48% Today?
↗
November 02, 2022
Benefitfocus (BNFT) stock is rocketing higher on Wednesday as investors react to a $570 million acquisition deal with Voya Financial (VOYA).
Via
InvestorPlace
Why Is Arcturus Therapeutics (ARCT) Stock Up 30% Today?
↗
November 02, 2022
The run-up in ARCT stock is practically unstoppable as two science-focused firms collaborate to develop mRNA technology.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
↗
November 02, 2022
Upgrades
Via
Benzinga
BARDA Backs Arcturus' Influenza Vaccine Program
↗
September 01, 2022
Via
Benzinga
Arcturus' COVID-19 Booster Shows Durability Against Omicron Variants
↗
August 18, 2022
Via
Benzinga
4 Analysts Have This to Say About Arcturus Therapeutics
↗
August 10, 2022
Within the last quarter, Arcturus Therapeutics (NASDAQ:ARCT) has observed the following analyst ratings:
Via
Benzinga
What 4 Analyst Ratings Have To Say About Arcturus Therapeutics
↗
November 02, 2022
Arcturus Therapeutics (NASDAQ:ARCT) has observed the following analyst ratings within the last quarter:
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
November 02, 2022
Gainers Monopar Therapeutics (NASDAQ:MNPR) shares increased by 53.0% to $4.09 during Wednesday's pre-market session. The company's market cap stands at $52.0 million.
Via
Benzinga
Why Rogers Shares Are Trading Sharply Lower; Here Are 33 Stocks Moving Premarket
↗
November 02, 2022
Gainers Avinger, Inc. (NASDAQ: AVGR) rose 32% to $1.36 in pre-market trading. Avinger is expected to release its financial results for the third quarter on Wednesday, November 9, 2022.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
November 02, 2022
Good morning, trader! It's time to take a look at all of the latest news behind the biggest pre-market stock movers on Thursday!
Via
InvestorPlace
Recap: Arcturus Therapeutics Q2 Earnings
↗
August 09, 2022
Arcturus Therapeutics (NASDAQ:ARCT) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Match Group, Super Micro Computer And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
↗
November 02, 2022
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Arcturus Announces Collaboration with CSL to Develop and Commercialize Self-amplifying mRNA Vaccines
November 01, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 9, 2022
October 26, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Micron, Charles River Laboratories And Some Other Big Stocks Moving Higher On Friday
↗
September 30, 2022
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining more than 80 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Arcturus Therapeutics to Attend the Following Investor Conferences
September 27, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
7 Small-Cap Stocks to Buy on the Dip or You’ll Be Kicking Yourself Later
↗
September 22, 2022
With the market taking a dip and possibly poised to incur more red ink, these are the small-cap stocks to buy that appeal to contrarians.
Via
InvestorPlace
Arcturus Therapeutics to Attend the Following Investor Conferences
September 01, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Announces $63.2 Million Award from the U.S. Government to Support Development of Self-amplifying mRNA Vaccine for Rapid Pandemic Influenza Response
August 31, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Reports Durability Data Against Omicron Variants, Including BA.5, at Six-Month Timepoint Following Booster with ARCT-154 COVID-19 Vaccine
August 18, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2022
↗
August 10, 2022
Via
Benzinga
Arcturus Therapeutics Announces Second Quarter 2022 Financial Update and Pipeline Progress
August 09, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
